CRDF vs KMX · rev $145.0K vs P/E 19, rev $25.88B
Cardiff Oncology Inc (CRDF) versus CarMax Inc (KMX) — a side-by-side from cached financials, not a winner call.
Cardiff Oncology Inc (CRDF) is a biotechnology company listed on US.
CarMax Inc (KMX) is a auto & truck dealerships company listed on US.
Latest reported CRDF revenue for 2026-06-30 was $145.0K. Net income was -$21.6M. CRDF currently screens at market cap $238.8M.
Latest reported KMX revenue for 2026-02-28 was $25.88B. Net income was $247.3M. Revenue was down 1.8% from 2025-02-28 to 2026-02-28. KMX currently screens at market cap $10.26B and trailing P/E 18.9.
CRDF currently screens at market cap $238.8M. KMX currently screens at market cap $10.26B and trailing P/E 18.9.
Not investment advice. Open the CRDF and KMX stock pages for the full models.
Not investment advice.